Big Pharma Slashes Spending On Doctors’ Sales Talks

free biotech news

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Some of the nation’s largest pharmaceutical companies have dramatically reduced payments to health professionals for promotional speeches amid heightened public scrutiny of such spending, a ProPublica analysis shows. Eli Lilly & Co.'s payments to speakers dropped by 55 percent, from $47.9 million in 2011 to $21.6 million in 2012. Pfizer’s speaking payments fell 62 percent over the same period, from nearly $22 million to $8.3 million.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC